Business Trip
En podcast av Greg Kubin & Matias Serebrinsky - Torsdagar
59 Avsnitt
-
What's wrong with US healthcare and how startups can fix it, with Justin Mares
Publicerades: 2025-04-17 -
Frontier investable areas in brain health with PsyMed Ventures
Publicerades: 2025-02-25 -
Temporal Interference: The Future of Brain Stimulation with Nir Grossman
Publicerades: 2025-01-30 -
The State of Autism Part 2 with James Adams of Gut-Brain-Axis Therapeutics Inc.
Publicerades: 2024-12-26 -
The State of Autism Part 1 with Elizabeth Horn of 2m Foundation
Publicerades: 2024-12-12 -
Genetic Medicine for Brain Health with Dana Watt of Breakout Ventures
Publicerades: 2024-11-14 -
Transcranial Focused Ultrasound for Mental Health with Jay Sanguinetti of Sanmai
Publicerades: 2024-09-05 -
Navigating FDA clinical trials in Neurotech with Tim Marjenin
Publicerades: 2024-08-23 -
Environmental Toxins and Mental Health with Gurdane Bhutani
Publicerades: 2024-07-18 -
FDA advisors say no to MDMA. What’s the impact? With Josh Hardman
Publicerades: 2024-06-21 -
Investing in New Frontiers of Mental Health (Live at SXSW)
Publicerades: 2024-05-07 -
Comparing Psychedelic Compounds in Therapy (Live Panel at Battery SF)
Publicerades: 2024-04-09 -
What Payers Want with Lili Brillstein
Publicerades: 2024-03-14 -
Decoding the Brain with Ed Boyden
Publicerades: 2024-02-22 -
5-MeO-DMT in mental healthcare with Steve Rio
Publicerades: 2024-01-25 -
Tom Insel: Startups, AI, Psychedelics, and SSRIs
Publicerades: 2023-12-15 -
Food as Medicine for Mental Health: Drew Ramsey
Publicerades: 2023-11-30 -
Ketogenic Diet for Brain Health: Jan Baszucki
Publicerades: 2023-11-16 -
Investing in Neurotech 101: Alex Morgan of Khosla Ventures
Publicerades: 2023-11-02 -
All you need is d̶r̶u̶g̶s̶ energy: Motif Neurotech's Implants for Depression
Publicerades: 2023-10-20
Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more.
